Tvardi Therapeutics, Inc. · NASDAQ:TVRD
Slate Path Capital LP reported a 7.50% stake in Tvardi Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 14, 2025
Slate Path Capital LP reported a 7.50% stake in Tvardi Therapeutics, Inc., 704,118 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G).
- Stake
- 7.50%
- Shares
- 704,118
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Slate Path Capital LP | 7.50% | 704,118 |
| David Greenspan | 7.50% | 704,118 |
Source
Related
- Tvardi Therapeutics, Inc.
- Slate Path Capital LP
- Tvardi Therapeutics, Inc. shareholders
- Schedule 13G/A · Ronald A. DePinho · Feb 17, 2026
- Schedule 13G/A · Ronald A. DePinho · Nov 14, 2025
- Schedule 13G · Sporos Bioventures LLC · Aug 8, 2025
- Schedule 13G/A · Samuel D. Tweardy · Aug 5, 2025
- Schedule 13G · Ronald A. DePinho · Jun 2, 2025